RPG Life Sciences Limited (RPGLIFE)
🎯 Key Takeaways
- RPG Life Sciences Limited is a mid-sized, diversified pharmaceutical company with a strong domestic footprint and growing international presence, operating in formulations and APIs across key therapeutic areas like nephrology, rheumatology, and oncology. It has demonstrated consistent revenue growth and healthy margins, supported by strategic expansion and a focus on inorganic growth opportunities.
- ⚠️ Exposure to regulatory and pricing pressures in international markets could impact API and formulation margins. Dependence on a few therapeutic segmen
📖 The Story
RPG Life Sciences Limited is a mid-sized, diversified pharmaceutical company with a strong domestic footprint and growing international presence, operating in formulations and APIs across key therapeutic areas like nephrology, rheumatology, and oncology. It has demonstrated consistent revenue growth and healthy margins, supported by strategic expansion and a focus on inorganic growth opportunities. The company maintains a robust cash position and has recently signaled shareholder-friendly policies through a high-yield dividend.
📰 What's Happening
In its FY2025-26 annual report, management highlighted 8.3% revenue growth to ₹707.5 crores and an EBITDA margin of 24.4%, driven by strong performance in nephrology (55.2%) and rheumatology (40.2%) segments. The company emphasized its US$5.2 billion diversified portfolio and strategic focus on market expansion and inorganic growth. A final dividend of Rs. 24 per share (300% yield) was declared, to be paid after AGM approval on July 23, 2026, with the record date to be set post-AGM. The 19th AGM is scheduled for July 23, 2026, and the annual report is now publicly available.
Source: Stock Announcements
🔮 Management Outlook & What's Next
Management has expressed confidence in sustaining growth through market expansion and inorganic opportunities, as noted in the annual report. The company is actively managing shareholder communications and regulatory compliance, including KYC updates and electronic dividend payments. No forward earnings guidance was provided in the latest filings, but the focus remains on strategic consolidation and capitalizing on therapeutic segment growth.
Extracted from official company announcements. Not StockFin.ai's opinion.
⚖️ Peer Comparison — Pharmaceuticals & Biotechnology
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 4.51 L Cr | 41.3 | 20.3% | 15.1% | 0.03 |
| Divi's Laboratories Limited | 1.79 L Cr | 72.4 | 22.1% | 16.6% | 0.00 |
| Torrent Pharmaceuticals Limited | 1.49 L Cr | 80.1 | — | — | — |
| Cipla Limited | 1.16 L Cr | 25.4 | 19.4% | 14.6% | 0.00 |
| Dr. Reddy's Laboratories Limited | 1.12 L Cr | 20.0 | 19.7% | 16.6% | 0.12 |
| Lupin Limited | 1.04 L Cr | 36.2 | — | — | — |
| Mankind Pharma Limited | 1.03 L Cr | 49.2 | — | — | — |
| Zydus Lifesciences Limited | 1.02 L Cr | 22.5 | — | — | — |
| Aurobindo Pharma Limited | 87,806 | 25.3 | — | — | — |
| Laurus Labs Limited | 71,455 | 356.8 | — | — | — |
🔗 Peer Stock Analyses
⚠️ Risk Factors
Exposure to regulatory and pricing pressures in international markets could impact API and formulation margins. Dependence on a few therapeutic segments for growth introduces concentration risk. Integration risks associated with potential acquisitions, if any, may affect execution of inorganic growth plans. Additionally, global macroeconomic and foreign exchange volatility could affect profitability of overseas operations.
📋 Recent Filings
-
Announcement 13 July 2026RPG Life Sciences announced receipt of a SEBI-mandated compliance certificate from MUFG Intime India confirming dematerialization of securities for th...
-
Announcement 13 July 2026RPG Life Sciences announced a partnership with Archerchem Healthcare to launch Naprosyn ES, a combination NSAID drug for pain management with gastro-p...
-
🔴 annual report 2 July 2026RPG Life Sciences Limited announced that its 2025-26 Annual Report is now available on its website and stock exchange portals, and reminded shareholde...
-
🔴 annual report 1 July 2026The filing announces the 19th AGM of RPG Life Sciences Limited scheduled for July 23, 2026, via video conferencing, and includes the Annual Report FY ...
-
Financial Results 25 June 2026RPG Life Sciences Limited announced that its trading window will close on July 1, 2026, ahead of the unaudited Q3 results declaration, remaining close...
-
🔴 Corporate Action 22 June 2026RPG Life Sciences announced a final dividend of Rs. 24 per share (300% yield) on its Rs. 8 face value equity shares for FY 2025-26, to be paid after s...
-
🟡 Board Meeting 16 June 2026RPG Life Sciences cancelled the erroneous record date of June 19, 2026 for final dividend eligibility entered on the NEAPS portal, clarifying that the...
-
Announcement 11 June 2026No summary available
-
🔴 Announcement 9 June 2026No summary available
-
🟡 Board Meeting 9 June 2026RPG Life Sciences announced a final dividend of Rs.24 per share (300% on Rs.8 face value) for FY 2025-26, payable after tax deductions at source as pe...
🧠 Analyst's Read
RPG Life Sciences is executing a stable growth strategy with strong cash flows and shareholder-friendly returns, but lacks explicit forward guidance. Investors should monitor AGM outcomes, dividend payment timelines, and any updates on inorganic growth plans or international segment performance in the coming quarters.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-20.
📡 Get AI alerts when RPGLIFE files new disclosures
Track RPGLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track RPGLIFE — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research